Synergy Groups Medical LLC

The trials here

What the 5 trials at this site are about, from their registry records.

Conditions

• ADHD1 trial
• COPD1 trial
• Gout1 trial
• Osteoarthritis1 trial
• Type 1 diabetes1 trial
• Type 2 diabetes1 trial

Phase

• Phase 32 trials
• Phase 1/21 trial
• Phase 21 trial
• Phase 41 trial

Status

• Completed4 trials
• Active, not recruiting1 trial

Lead sponsor

• Amgen1 trial
• Biomea Fusion Inc.1 trial
• Biosplice Therapeutics, Inc.1 trial
• Otsuka Pharmaceutical Development & Commercialization, Inc.1 trial
• Upstream Bio Inc.1 trial

Running trials

• Active, not recruiting

  A Study to Assess the Efficacy and Safety of Verekitug in Participants With COPD

  NCT06981078· Phase 2· Upstream Bio Inc.· Source

Closed trials

• Completed

  A Trial to Investigate the Non-inferiority of Pegloticase Administered Every 4 Weeks (Q4W) With MTX Compared With Every 2 Weeks (Q2W) With MTX in Participants With Uncontrolled Refractory Gout

  NCT06229145· Phase 4· Amgen· Source

• Completed

  Safety and Efficacy of Lorecivivint (SM04690) for the Treatment of Knee Osteoarthritis (STRIDES)

  NCT05603754· Phase 3· Biosplice Therapeutics, Inc.· Source

• Completed

  Study of BMF-219 in Healthy Adult Subjects and in Adult Subjects With Type 2 Diabetes Mellitus (T2D)

  NCT05731544· Phase 1/2· Biomea Fusion Inc.· Source

• Completed

  A Trial of Centanafadine Long-term Safety in Children and Adolescents With Attention-deficit/Hyperactivity Disorder.

  NCT05279313· Phase 3· Otsuka Pharmaceutical Development & Commercialization, Inc.· Source